[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors",
    "summary": "Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=97e07341275215b42d21d8a30a8dc6c5860d121b27c213079eb3b800688f8435",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743438960,
      "headline": "Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors",
      "id": 133638616,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=97e07341275215b42d21d8a30a8dc6c5860d121b27c213079eb3b800688f8435"
    }
  },
  {
    "ts": null,
    "headline": "Intellia Focuses on Pipeline Development Amid Stiff Competition",
    "summary": "Studies on NTLA's gene-edited therapy, nex-z, are progressing well while other pipelines are picking up pace. Stiff competition in the target market is a woe.",
    "url": "https://finnhub.io/api/news?id=8195ef88c62076e0d29f7e1998b1800e0b7f49a7f07c30bf70afca5baf173fc1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743430200,
      "headline": "Intellia Focuses on Pipeline Development Amid Stiff Competition",
      "id": 133627901,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Studies on NTLA's gene-edited therapy, nex-z, are progressing well while other pipelines are picking up pace. Stiff competition in the target market is a woe.",
      "url": "https://finnhub.io/api/news?id=8195ef88c62076e0d29f7e1998b1800e0b7f49a7f07c30bf70afca5baf173fc1"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer on Vertex Pharmaceuticals (VRTX): “Revolutionary Pain Drug on the Horizon!”",
    "summary": "We recently published a list of Jim Cramer Looked At These 23 Stocks Recently. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other stocks that Jim Cramer looked at recently. Jim Cramer, the host of Mad Money, offered an optimistic perspective on the market on […]",
    "url": "https://finnhub.io/api/news?id=d95f8d09f5c9e7782b3eb79c89d9ce8dbfd7d263069bb4ce4c38b86bb33c1052",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743428032,
      "headline": "Jim Cramer on Vertex Pharmaceuticals (VRTX): “Revolutionary Pain Drug on the Horizon!”",
      "id": 133627902,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "We recently published a list of Jim Cramer Looked At These 23 Stocks Recently. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other stocks that Jim Cramer looked at recently. Jim Cramer, the host of Mad Money, offered an optimistic perspective on the market on […]",
      "url": "https://finnhub.io/api/news?id=d95f8d09f5c9e7782b3eb79c89d9ce8dbfd7d263069bb4ce4c38b86bb33c1052"
    }
  },
  {
    "ts": null,
    "headline": "Vertex halts development of diabetes cell therapy after trial failure",
    "summary": "Vertex continues to develop type 1 diabetes therapy, zimislecel, which is being investigated in a Phase III trial.",
    "url": "https://finnhub.io/api/news?id=9245b0e3c5b44be3cd08cc75f33f1adb04ec21571f8e7b66e5f7b5558e92f540",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743420937,
      "headline": "Vertex halts development of diabetes cell therapy after trial failure",
      "id": 133625700,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex continues to develop type 1 diabetes therapy, zimislecel, which is being investigated in a Phase III trial.",
      "url": "https://finnhub.io/api/news?id=9245b0e3c5b44be3cd08cc75f33f1adb04ec21571f8e7b66e5f7b5558e92f540"
    }
  },
  {
    "ts": null,
    "headline": "PGIM Jennison Global Opportunities Fund Q4 2024 Commentary",
    "summary": "The PGIM Jennison Global Opportunities Fund returned -0.6%, holding up slightly better than the MSCI ACWI Index. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=4e3ccc7be59fb7d5a1ce2d2968438f82e1cc05399ebdc5fbccad36a50cfe99f3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743419700,
      "headline": "PGIM Jennison Global Opportunities Fund Q4 2024 Commentary",
      "id": 133626837,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2206067205/image_2206067205.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "The PGIM Jennison Global Opportunities Fund returned -0.6%, holding up slightly better than the MSCI ACWI Index. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=4e3ccc7be59fb7d5a1ce2d2968438f82e1cc05399ebdc5fbccad36a50cfe99f3"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Incorporated : 2024 (2024 Political Engagement Principles)",
    "summary": "POLITICAL ENGAGEMENT PRINCIPLES Our Mission Every day, Vertexians work hard to improve the lives of patients. In so doing, we recognize the importance of...",
    "url": "https://finnhub.io/api/news?id=09fd4a7ea73a953e870eecd0105ed1077cb09a2adf7a43eafdeae0d9b24ab4a6",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743416586,
      "headline": "Vertex Pharmaceuticals Incorporated : 2024 (2024 Political Engagement Principles)",
      "id": 133626501,
      "image": "",
      "related": "VRTX",
      "source": "Finnhub",
      "summary": "POLITICAL ENGAGEMENT PRINCIPLES Our Mission Every day, Vertexians work hard to improve the lives of patients. In so doing, we recognize the importance of...",
      "url": "https://finnhub.io/api/news?id=09fd4a7ea73a953e870eecd0105ed1077cb09a2adf7a43eafdeae0d9b24ab4a6"
    }
  },
  {
    "ts": null,
    "headline": "PGIM Jennison Focused Growth Fund Q4 2024 Commentary",
    "summary": "PGIM Jennison Focused Growth Fund Q4 2024 Commentary",
    "url": "https://finnhub.io/api/news?id=737ff5ee66dd78153317776bacd4fec7f6e999436982756dea21c4a22bae1c46",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743403200,
      "headline": "PGIM Jennison Focused Growth Fund Q4 2024 Commentary",
      "id": 133624801,
      "image": "",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=737ff5ee66dd78153317776bacd4fec7f6e999436982756dea21c4a22bae1c46"
    }
  }
]